IBDEI0EU ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7139,0)
 ;;=694.5^^49^554^95
 ;;^UTILITY(U,$J,358.3,7139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7139,1,3,0)
 ;;=3^Pemphigoid
 ;;^UTILITY(U,$J,358.3,7139,1,4,0)
 ;;=4^694.5
 ;;^UTILITY(U,$J,358.3,7139,2)
 ;;=Pemphigoid^91108
 ;;^UTILITY(U,$J,358.3,7140,0)
 ;;=364.10^^49^554^54
 ;;^UTILITY(U,$J,358.3,7140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7140,1,3,0)
 ;;=3^Iridocyclitis, Chronic
 ;;^UTILITY(U,$J,358.3,7140,1,4,0)
 ;;=4^364.10
 ;;^UTILITY(U,$J,358.3,7140,2)
 ;;=Iridocyclitis, Chronic^24398
 ;;^UTILITY(U,$J,358.3,7141,0)
 ;;=054.44^^49^554^55
 ;;^UTILITY(U,$J,358.3,7141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7141,1,3,0)
 ;;=3^Iridocyclitis, H Simplex
 ;;^UTILITY(U,$J,358.3,7141,1,4,0)
 ;;=4^054.44
 ;;^UTILITY(U,$J,358.3,7141,2)
 ;;=Iridocyclitis, H Simplex^266565
 ;;^UTILITY(U,$J,358.3,7142,0)
 ;;=053.22^^49^554^56
 ;;^UTILITY(U,$J,358.3,7142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7142,1,3,0)
 ;;=3^Iridocyclitis, H Zoster
 ;;^UTILITY(U,$J,358.3,7142,1,4,0)
 ;;=4^053.22
 ;;^UTILITY(U,$J,358.3,7142,2)
 ;;=Iridocyclitis, H Zoster^266554
 ;;^UTILITY(U,$J,358.3,7143,0)
 ;;=364.42^^49^554^111
 ;;^UTILITY(U,$J,358.3,7143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7143,1,3,0)
 ;;=3^Rubeosis Iridis
 ;;^UTILITY(U,$J,358.3,7143,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,7143,2)
 ;;=Rubeosis Iridis^268716
 ;;^UTILITY(U,$J,358.3,7144,0)
 ;;=364.59^^49^554^59
 ;;^UTILITY(U,$J,358.3,7144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7144,1,3,0)
 ;;=3^Iris Atrophy,Other
 ;;^UTILITY(U,$J,358.3,7144,1,4,0)
 ;;=4^364.59
 ;;^UTILITY(U,$J,358.3,7144,2)
 ;;=Iris Atrophy^268731
 ;;^UTILITY(U,$J,358.3,7145,0)
 ;;=224.0^^49^554^11
 ;;^UTILITY(U,$J,358.3,7145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7145,1,3,0)
 ;;=3^Benign Neopl of Iris
 ;;^UTILITY(U,$J,358.3,7145,1,4,0)
 ;;=4^224.0
 ;;^UTILITY(U,$J,358.3,7145,2)
 ;;=^267670
 ;;^UTILITY(U,$J,358.3,7146,0)
 ;;=364.72^^49^554^6
 ;;^UTILITY(U,$J,358.3,7146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7146,1,3,0)
 ;;=3^Anterior Synechiae
 ;;^UTILITY(U,$J,358.3,7146,1,4,0)
 ;;=4^364.72
 ;;^UTILITY(U,$J,358.3,7146,2)
 ;;=Anterior Synechiae^265517
 ;;^UTILITY(U,$J,358.3,7147,0)
 ;;=364.71^^49^554^102
 ;;^UTILITY(U,$J,358.3,7147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7147,1,3,0)
 ;;=3^Posterior Synechiae
 ;;^UTILITY(U,$J,358.3,7147,1,4,0)
 ;;=4^364.71
 ;;^UTILITY(U,$J,358.3,7147,2)
 ;;=Posterior Synechiae^265519
 ;;^UTILITY(U,$J,358.3,7148,0)
 ;;=364.00^^49^554^57
 ;;^UTILITY(U,$J,358.3,7148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7148,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,7148,1,4,0)
 ;;=4^364.00
 ;;^UTILITY(U,$J,358.3,7148,2)
 ;;=Iridocyclitis, Acute^268703
 ;;^UTILITY(U,$J,358.3,7149,0)
 ;;=379.40^^49^554^106
 ;;^UTILITY(U,$J,358.3,7149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7149,1,3,0)
 ;;=3^Pupil, Abnormal function
 ;;^UTILITY(U,$J,358.3,7149,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,7149,2)
 ;;=Pupil, Abnormal function^101288
 ;;^UTILITY(U,$J,358.3,7150,0)
 ;;=190.0^^49^554^84
 ;;^UTILITY(U,$J,358.3,7150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7150,1,3,0)
 ;;=3^Malig Neopl of Eyeball,Iris
 ;;^UTILITY(U,$J,358.3,7150,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,7150,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,7151,0)
 ;;=190.3^^49^554^83
 ;;^UTILITY(U,$J,358.3,7151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7151,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,7151,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,7151,2)
 ;;=Malig Neopl Conjunctiva^267274
